Autotaxin (ATX) isoforms in epithelial ovarian cancer (EOC).

被引：0
|
作者：
Shankar, S [1 ]
Kung, A [1 ]
Fishman, DA [1 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
来源：
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION | 2004年 / 11卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
994
引用
收藏
页码：410A / 410A
页数：1
相关论文
共 50 条
  • [31] THE ROLE OF SECONDARY CYTOREDUCTIVE SURGERY (SCR) IN RELAPSED EPITHELIAL OVARIAN CANCER (EOC)
    Kolomainen, D. F.
    Rzyska, E.
    Ind, T. E. J.
    Nobbenhuis, M. A. E.
    Kaye, S. B.
    Mohammed, K.
    Sohaib, A.
    Bridges, J. E.
    Shepherd, J. H.
    Gore, M. E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [32] Autotaxin (ATX) inhibits autophagy leading to exaggerated disruption of intestinal epithelial barrier in colitis
    Shi, Wenjie
    Peng, Kaixin
    Yu, Hongbing
    Wang, Zi
    Xia, Shuhong
    Xiao, Siqi
    Tian, Dean
    Vallance, Bruce A.
    Yu, Qin
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2023, 1869 (04):
  • [33] BRCA MUTATION ANALISYS IN A COHORT OF EPITHELIAL OVARIAN CANCER (EOC) PATIENTS IN A BRAZILIAN CANCER HOSPITAL
    Cintra, G. F.
    Galvao, H. C. R.
    Vieira, M. A.
    Reis, R.
    Andrade, C. E. M. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 179 - 180
  • [34] PATTERN OF INTRAPERITONEAL SPREAD IN EPITHELIAL OVARIAN-CANCER (EOC) - A NEW PROGNOSTIC FACTOR
    VARMA, R
    BLACKLEDGE, G
    LUESLEY, D
    CHAN, KK
    KELLY, K
    BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 499 - 499
  • [35] Advanced epithelial ovarian cancer (EOC): Is there a place for maintenance therapy in patients with suboptimal debulking?
    Hariprasad, R.
    Kumar, L.
    Kumar, S.
    Bhatla, N.
    Thulkar, S.
    Das, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] Impact of genomic heterogeneity and mutation patterns on the outcome of patients with epithelial ovarian cancer (EOC)
    Kotoula, V.
    Lakis, S.
    Giannoulatou, E.
    Kouvatseas, G.
    Lazaridis, G.
    Tikas, I.
    Efstratiou, I.
    Chrisafi, S.
    Charalambous, E.
    Papanikolaou, A.
    Fostira, F.
    Tarlatzis, B.
    Fountzilas, G.
    ANNALS OF ONCOLOGY, 2016, 27
  • [37] Neoadjuvant chemotherapy (NACT) in advanced epithelial ovarian cancer (EOC) with single agent carboplatin
    Gupta, Sudeep
    Biswas, G.
    Parkh, P. M.
    Maheshwari, A.
    Kerkar, R.
    Tongaonkar, H. B.
    ANNALS OF ONCOLOGY, 2004, 15 : 121 - 122
  • [38] ROLE OF TUMOR MARKERS IN CLINICAL RESPONSE TO THERAPY IN PATIENTS WITH EPITHELIAL OVARIAN CANCER (EOC)
    Macchi, C.
    Calavita, F.
    Danna, P.
    Mitidieri, M.
    De Ruvo, D.
    Male, E.
    Zola, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1582 - 1582
  • [39] Tissue Transglutaminase (TG2) in Normal Ovary and Epithelial Ovarian Cancer (EOC).
    Harlow, Christopher R.
    Zhao, Rui
    Zhou, Jieqian
    Wu, Xuan
    Critchley, Hilary O. D.
    Hillier, Stephen G.
    REPRODUCTIVE SCIENCES, 2010, 17 (03) : 114A - 115A
  • [40] Follicle Stimulating Hormone Receptor (FSHR) Gene and Postmenopausal Epithelial Ovarian Cancer (EOC)
    Bose, Chinmoy K.
    JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2006, 7 (04) : 346 - 349
12345